Neovacs S.A. (ALNEV) — Net Asset Quality Index
Neovacs S.A. (ALNEV) has a Net Asset Quality Index of 81.9% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €23.07 Million minus total liabilities of €4.18 Million yields net assets of €18.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Neovacs S.A. liquidity resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Neovacs S.A. Net Asset Quality Index Over Time (2007–2024)
This chart shows how Neovacs S.A.'s Net Asset Quality Index has evolved across 18 annual periods from 2007 to 2024. As of June 2025, the index stands at 81.9%, representing net assets of €18.89 Million against total assets of €23.07 Million EUR. See ALNEV working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Neovacs S.A. (2007–2024)
The table below presents the year-by-year Net Asset Quality Index for Neovacs S.A. from 2007 to 2024, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ALNEV market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 81.8% | €18.06 Million | €22.07 Million | €4.01 Million | ▼ -10.4 pp |
| 2023 | 92.2% | €43.82 Million | €47.53 Million | €3.71 Million | ▲ +2.4 pp |
| 2022 | 89.7% | €44.23 Million | €49.28 Million | €5.05 Million | ▼ -0.7 pp |
| 2021 | 90.4% | €43.90 Million | €48.55 Million | €4.65 Million | ▲ +9.0 pp |
| 2020 | 81.4% | €10.98 Million | €13.49 Million | €2.50 Million | ▲ +45.1 pp |
| 2019 | 36.3% | €2.74 Million | €7.54 Million | €4.80 Million | ▲ +2.7 pp |
| 2018 | 33.7% | €2.44 Million | €7.24 Million | €4.80 Million | ▲ +26.4 pp |
| 2017 | 7.2% | €845.75K | €11.67 Million | €10.82 Million | ▼ -6.2 pp |
| 2016 | 13.5% | €1.26 Million | €9.33 Million | €8.08 Million | ▼ -40.5 pp |
| 2015 | 53.9% | €6.07 Million | €11.25 Million | €5.18 Million | ▼ -7.6 pp |
| 2014 | 61.5% | €5.57 Million | €9.05 Million | €3.49 Million | ▲ +16.1 pp |
| 2013 | 45.4% | €3.48 Million | €7.67 Million | €4.19 Million | ▼ -12.9 pp |
| 2012 | 58.3% | €3.62 Million | €6.21 Million | €2.59 Million | ▼ -23.1 pp |
| 2011 | 81.4% | €10.57 Million | €12.98 Million | €2.41 Million | ▲ +3.9 pp |
| 2010 | 77.5% | €8.27 Million | €10.68 Million | €2.40 Million | ▲ +85.3 pp |
| 2009 | -7.8% | €-352.58K | €4.52 Million | €4.88 Million | ▼ -82.6 pp |
| 2008 | 74.8% | €6.51 Million | €8.70 Million | €2.19 Million | ▲ +25.6 pp |
| 2007 | 49.2% | €1.97 Million | €4.01 Million | €2.04 Million | — |